EyePoint Pharmaceuticals Inc (EYPT)

[LongRun8]

I do think that it'll be approved this time. I wish more studies or info had been done to show the FDA that the side effect profile isn't as bad as they seem to think. I'm assuming that PSDV really thinks that it'll get approved this time by narrowing the patient population like they did. This is obviously the less expensive route for PSDV just to change the patient population rather than conducting more studies. So for shareholder value, I guess, getting approval this way will be better in the long run. I don't think it's a slam dunk, but I do think it'll get approved.
Take care and good luck.